Annals of Intensive CarePub Date : 2026-10-29eCollection Date: 2026-01-01DOI: 10.1016/j.aicoj.2026.100195
S Benghanem, E Pruvost-Robieux, G Hmeydia, H Sellami, J Mercier, M Gavaret, T Sharshar, A Cariou, C Calligaris, C Legouy
{"title":"Neuroprognostication in unconscious patients after cardiac arrest: considering the time course of prognostic markers.","authors":"S Benghanem, E Pruvost-Robieux, G Hmeydia, H Sellami, J Mercier, M Gavaret, T Sharshar, A Cariou, C Calligaris, C Legouy","doi":"10.1016/j.aicoj.2026.100195","DOIUrl":"https://doi.org/10.1016/j.aicoj.2026.100195","url":null,"abstract":"<p><p>Hypoxic-ischemic brain injury (HIBI) is a major determinant of outcome after cardiac arrest (CA) and accounts for approximately two-thirds of deaths in patients who remain comatose after return of spontaneous circulation (ROSC), frequently following withdrawal of life-sustaining therapy (WLST) based on an anticipated poor neurological prognosis. Accurate neuroprognostication is therefore crucial to identify patients with potential for neurological recovery while avoiding premature pessimistic predictions. Current guidelines recommend a multimodal approach integrating clinical examination, electrophysiology, biomarkers, and neuroimaging. However, neuroprognostication is inherently time-dependent: HIBI is a dynamic process, and the prognostic value of individual markers evolves substantially during the hours and days following CA. Some markers may provide relevant prognostic information early after ROSC, whereas others achieve optimal accuracy only after 24-72 h or later, as brain injury evolves and confounding factors progressively resolve. Thus, both the selection of prognostic markers and the timing of their assessment are critical to optimize prognostic accuracy. This review summarizes the temporal evolution of the prognostic performance of clinical examination, electroencephalography, somatosensory evoked potentials, biomarkers of brain injury, and neuroimaging after CA, and discusses how their integration according to optimal assessment windows may improve multimodal neuroprognostication and reduce prognostic uncertainty.</p>","PeriodicalId":7966,"journal":{"name":"Annals of Intensive Care","volume":"16 ","pages":"100195"},"PeriodicalIF":6.9,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13761240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Outcomes of extracorporeal membrane oxygenation in critically ill patients with sickle cell disease: a systematic review and meta-analysis.","authors":"Laure Flurin, Elsa Vidal, Thibault Parent, Amélie Rollé","doi":"10.1016/j.aicoj.2026.100194","DOIUrl":"https://doi.org/10.1016/j.aicoj.2026.100194","url":null,"abstract":"<p><strong>Purpose: </strong>Extracorporeal membrane oxygenation (ECMO) may be considered as rescue therapy in patients with sickle cell disease (SCD) presenting with life-threatening cardiorespiratory failure, particularly acute chest syndrome (ACS). However, outcomes of ECMO in this population remain poorly defined, especially in adult populations. We aimed to synthesize available evidence on mortality and complications associated with ECMO use in adult and pediatric populations with SCD.</p><p><strong>Methods: </strong>We conducted a systematic review and meta-analysis of observational studies reporting ECMO use in patients with confirmed SCD. MEDLINE, EMBASE, PubMed, and the Cochrane Central Register of Controlled Trials were searched from January 2000 to January 2025. Risk of bias for included studies was assessed using the ROBINS-I tool. Random-effects meta-analysis of proportions was performed to estimate pooled mortality. Exploratory study-level meta-regression was used to examine associations between mortality and prespecified moderators, including age group, ECMO modality, and ACS as the indication for ECMO.</p><p><strong>Results: </strong>Seven retrospective studies including 252 patients were included in the meta-analysis. The pooled mortality estimate was 64.5% (95% CI, 39.3-86.0%), with heterogeneity across studies (I² = 80%). Mortality estimates appeared numerically higher in studies including predominantly adult populations, greater use of veno-arterial ECMO, and a higher proportion of patients with ACS at cannulation. Exploratory meta-regression suggested trends toward higher predicted mortality with increasing proportions of adult patients and ACS, and lower mortality with higher proportions of veno-venous ECMO. Reporting of ECMO-related complications was inconsistent, and hemolysis was systematically assessed in only one study.</p><p><strong>Discussion: </strong>ECMO use in patients with SCD is associated with high mortality, particularly in severe clinical contexts such as ACS. Substantial heterogeneity and methodological limitations preclude firm conclusions. These findings underscore the need for prospective, disease-specific registries to better define patient selection and management strategies.'</p>","PeriodicalId":7966,"journal":{"name":"Annals of Intensive Care","volume":"16 ","pages":"100194"},"PeriodicalIF":6.9,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13761238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Beyond blood glucose targets: integrating glucose variability into acute glycemic care in French ICUs - a multicenter prospective study.","authors":"Suzanne Goursaud, Toufik Kamel, Amandine Thierry, Laetitia Bodet-Contentin, Nahila Himer, Vanessa Zinzoni, Paul-Henry Wicky, Julien Lorber, Guylaine Labro, Anne-Astride Bourion, Sarah Noir, Evelina Ochin, Nathalie Regnier, Thibault Noel, Célina Morand, Adrien Auvet, Aude Garin, David Schnell, Vanessa Jean-Michel, David Joganah, Constance Grignon, Emmanuelle Mercier, Bertrand Hermann, Claire Dupuis, Laurent Poiroux","doi":"10.1016/j.aicoj.2026.100193","DOIUrl":"https://doi.org/10.1016/j.aicoj.2026.100193","url":null,"abstract":"<p><strong>Background: </strong>Although hyperglycemia is a common adaptative response in hospitalized intensive care units (ICUs) patients, there are no recommendations regarding blood glucose management protocols. Consequently, practices differ between ICUs. We aimed to prospectively describe glucose management in French-speaking ICUs with the main objective to assess the impact of glucose management on glucose variability within the first 48 h of insulin infusion.</p><p><strong>Results: </strong>A total of 650 patients from 38 ICUs across France and Belgium were included with 649 patients analyzed. Management with tighter glucose targets did not result in an increase in Glycemic Lability Index (OR 0.79, 95% CI [0.51-1.21]; <i>p</i> = 0.28) but episodes of severe hypoglycemia were more frequent in tight blood glucose control group. Nurse workload did not impact glucose variability significantly. Deviations from the protocol were frequent in 24.9% of cases, independently to the blood glucose target used. Percentage spent in the target range was significantly higher in the liberal group (<i>p</i> < 0.01). ICU mortality rate was higher in patients who had at least one episode of hypoglycemia <3.9 mmol/L (<i>p</i> = 0.04), and lower in patients with at least one episode of hyperglycemia >11.1 mmol/L (<i>p</i> = 0.04).</p><p><strong>Conclusions: </strong>Despite heterogenous practices through French speaking ICUs, management with tight blood glucose targets did not significantly impact glucose variability but was associated with higher incidence of severe hypoglycemia.</p>","PeriodicalId":7966,"journal":{"name":"Annals of Intensive Care","volume":"16 ","pages":"100193"},"PeriodicalIF":6.9,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13756784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Annals of Intensive CarePub Date : 2026-10-22eCollection Date: 2026-01-01DOI: 10.1016/j.aicoj.2026.100191
Fernando G Zampieri, Israel S Maia, Flavia R Machado, Alexandre B Cavalcanti
{"title":"Chloride load and serum chloride in critically ill adults: a randomization-anchored analysis of the BaSICS trial.","authors":"Fernando G Zampieri, Israel S Maia, Flavia R Machado, Alexandre B Cavalcanti","doi":"10.1016/j.aicoj.2026.100191","DOIUrl":"10.1016/j.aicoj.2026.100191","url":null,"abstract":"<p><strong>Background: </strong>0.9% saline solution has a supraphysiological chloride concentration and has been associated observationally with acute kidney injury and mortality. How randomized fluid type changes serum chloride early in critical illness, and what determines this change, remain uncertain. Focusing on the first three days after randomization, we estimated the randomized saline-versus-Plasma-Lyte difference in serum chloride and its variation by renal function, the observational association with study-saline volume, and the sources of variation in serum chloride.</p><p><strong>Methods: </strong>This secondary analysis of BaSICS (75 Brazilian ICUs; Plasma-Lyte 148 vs 0.9% saline) included participants with baseline serum chloride and at least one measurement on days 1-3. A Bayesian hierarchical longitudinal model estimated the treatment effect over time and its variation by baseline estimated glomerular filtration rate (eGFR). Group-level analyses used day 2, which balanced accumulated exposure against attrition of measurements. We normalized randomized between-group differences, estimated an inverse-probability-weighted within-saline volume association, and partitioned modeled variation in serum chloride.</p><p><strong>Results: </strong>Among 3,482 patients (33% of the trial population), serum chloride rose 2.15 mmol/L (95% confidence interval, 1.76-2.53) more with saline than with Plasma-Lyte by day 2, when saline recipients had received on average 145.7 mmol more study-fluid chloride, corresponding to 1.47 mmol/L per 100 mmol of additional chloride (1.17-1.81). Within saline recipients, the weighted association was +0.31 mmol/L per 100 mmol (0.22 to 0.44). The day-2 between-group difference decreased by 0.29 mmol/L (95% credible interval, 0.12 to 0.46) per 15 mL/min/1.73 m<sup>2</sup> higher baseline eGFR (+3.0 mmol/L at 30 vs +1.8 mmol/L at 90 mL/min/1.73 m<sup>2</sup>). Of modeled variation in serum chloride, the fluid component accounted for 0.7% (0.4-1.0; 1.8% with randomized arm included); measured baseline characteristics, almost entirely baseline serum chloride, for 48.1%; persistent patient-specific differences not explained by measured characteristics for 24.5%; and day-to-day within-patient fluctuation for 26.9%.</p><p><strong>Conclusions: </strong>Over the first three ICU days, randomization to saline increased serum chloride relative to Plasma-Lyte, and the between-group difference was larger at lower baseline eGFR. Most modeled variation in serum chloride reflected each patient's baseline chloride and persistent patient-specific differences that measured characteristics did not explain; the fluid component was small.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov, NCT02875873.</p>","PeriodicalId":7966,"journal":{"name":"Annals of Intensive Care","volume":"16 ","pages":"100191"},"PeriodicalIF":6.9,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13742502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149369843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Annals of Intensive CarePub Date : 2026-10-17eCollection Date: 2026-01-01DOI: 10.1016/j.aicoj.2026.100190
Elsa Hägglöf, Jesper Eriksson, Max Bell, Linn Hallqvist, Lars Engerström, Emma Larsson
{"title":"Sex differences in limitations of life-sustaining treatment in the intensive care unit: A nationwide cohort study.","authors":"Elsa Hägglöf, Jesper Eriksson, Max Bell, Linn Hallqvist, Lars Engerström, Emma Larsson","doi":"10.1016/j.aicoj.2026.100190","DOIUrl":"https://doi.org/10.1016/j.aicoj.2026.100190","url":null,"abstract":"<p><strong>Background: </strong>Previous research suggests that limitations of life-sustaining treatment (LST) may be more common in women than men, but few studies have included data on clinical reasoning or limitation type. This study aimed to investigate sex differences in LST-limitations in the ICU and in their documented characteristics.</p><p><strong>Methods: </strong>All adult (≥18 years) ICU patients registered in the Swedish Intensive Care Register between 2019 and 2024 were included. A multivariable logistic regression model, adjusted for SAPS3 and age, analysed the association between sex and LST-limitations. Limitation characteristics were compared using Chi-square test (categorical variables) and Wilcoxon rank-sum test (numeric variables).</p><p><strong>Results: </strong>The cohort included 111,354 patients; 41.7% women. LST-limitations occurred in 24.4% of patients and were more frequent in women than in men (25.3% vs. 23.8%, p < 0.0001). In adjusted analyses women had higher odds of receiving an LST-limitation than men, both in the full cohort (OR 1.21, 95% CI 1.17-1.25) and among 30-day non-survivors (OR 1.24, 95% CI 1.18-1.32). Women received LST-limitations earlier than men (2.8 h after admission vs 4.5 h, p < 0.0001). Acute disease and therapy failure were more often documented reasons in men than in women (78.8% vs 74.3%, p < 0.0001; 21.2% vs. 18.6%, p = 0.0001), whereas autonomy and chronic disease were more frequent in women (7.8% vs 5.9%, p < 0.0001; 63.2% vs. 60.7%, p = 0.0021). Women were more often involved in decision-making (13.3% vs 11.8%, p = 0.0074).</p><p><strong>Conclusions: </strong>Women were more likely to receive LST-limitations and received them earlier. Men who died within 30 days were less likely to have had an LST-limitation than women. Documented reasons for LST-limitations differed by sex, and women had higher rates of documented patient involvement.</p>","PeriodicalId":7966,"journal":{"name":"Annals of Intensive Care","volume":"16 ","pages":"100190"},"PeriodicalIF":6.9,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13740874/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149369844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Annals of Intensive CarePub Date : 2026-10-16eCollection Date: 2026-01-01DOI: 10.1016/j.aicoj.2026.100187
Tanmoy Ghatak, Kalavathy Swarna
{"title":"Letter to the Editor: Balancing the Pendulum-The Risks of Universal Fluid Restriction and Over-reliance on \"Static\" Phase Models.","authors":"Tanmoy Ghatak, Kalavathy Swarna","doi":"10.1016/j.aicoj.2026.100187","DOIUrl":"https://doi.org/10.1016/j.aicoj.2026.100187","url":null,"abstract":"","PeriodicalId":7966,"journal":{"name":"Annals of Intensive Care","volume":"16 ","pages":"100187"},"PeriodicalIF":6.9,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13695122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149261026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Annals of Intensive CarePub Date : 2026-10-15eCollection Date: 2026-01-01DOI: 10.1016/j.aicoj.2026.100185
Xiaoxue You, Yanqin Guo, Yuhua Liu
{"title":"Comments on Kroken et al.'s \"Long-term frailty trajectory in older ICU survivors requiring mechanical ventilation: a prospective cohort study in Norway\".","authors":"Xiaoxue You, Yanqin Guo, Yuhua Liu","doi":"10.1016/j.aicoj.2026.100185","DOIUrl":"10.1016/j.aicoj.2026.100185","url":null,"abstract":"","PeriodicalId":7966,"journal":{"name":"Annals of Intensive Care","volume":"16 ","pages":"100185"},"PeriodicalIF":6.9,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13734909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Annals of Intensive CarePub Date : 2026-10-14eCollection Date: 2026-01-01DOI: 10.1016/j.aicoj.2026.100186
Shirin Kordasti Frisvold, Bjorn Anders Kroken, Marina Espinasse, Hans Flaatten
{"title":"Comments on Kroken et al.'s \"Long-term frailty trajectory in older ICU survivors requiring mechanical ventilation: a prospective cohort study in Norway\"- Author's reply.","authors":"Shirin Kordasti Frisvold, Bjorn Anders Kroken, Marina Espinasse, Hans Flaatten","doi":"10.1016/j.aicoj.2026.100186","DOIUrl":"https://doi.org/10.1016/j.aicoj.2026.100186","url":null,"abstract":"","PeriodicalId":7966,"journal":{"name":"Annals of Intensive Care","volume":"16 ","pages":"100186"},"PeriodicalIF":6.9,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13721934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149317347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}